AB1295 ASSESSING GIANT CELL ARTERITIS ACTIVITY WITH [68GA]GA-DOTA-SIGLEC-9 PET-CT: A NOVEL IMAGING METHOD

正电子发射断层摄影术 医学 多塔 核医学 炎症 巨细胞动脉炎 PET-CT 分子成像 血管炎 病理 放射科 免疫学 生物 体内 疾病 生物技术
作者
Simon Michael Petzinna,J. Küppers,B. Schemmer,Anna L. Kernder,C. Bauer,Florian Gärtner,Markus Essler,V. S. Schaefer
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:: 1993.2-1994 被引量:1
标识
DOI:10.1136/annrheumdis-2024-eular.6134
摘要

Background:

Giant cell arteritis (GCA) is an immune-mediated granulomatous vasculitis affecting large and medium-sized vessels. Vascular ultrasound, the diagnostic gold standard, has limitations in evaluating the aorta. Therefore, positron emission tomography-computer tomography (PET-CT) with [18F]FDG has emerged as a diagnostic alternative. However, interpretation can be challenging as glucose metabolism also occurs in vascular remodeling. The novel radiotracer [68Ga]Ga-DOTA-Siglec-9 could improve PET-CT diagnostic capabilities. Early studies in animals and humans have validated its safety, tolerability, and potential efficacy in identifying inflammation. Siglec-9 is the leukocyte ligand for vascular adhesion protein 1 (VAP-1). Under physiological conditions, VAP-1 resides in intracellular vesicles within various cell types, including endothelial cells. Inflammatory stimuli prompt its translocation to the endothelial cell surface, enabling immune cell adhesion and migration. This upregulation of VAP-1 during inflammation renders [68Ga]Ga-DOTA-Siglec-9 PET-CT particularly interesting for GCA.

Objectives:

Evaluating [68Ga]Ga-DOTA-Siglec-9 PET-CT for Disease Activity Detection in Giant Cell Arteritis.

Methods:

We recruited a patient with recurrent GCA disease activity. The patient underwent a [68Ga]Ga-DOTA-Siglec-9 PET-CT scan with an injection of 120 MBq [68Ga]Ga-DOTA-Siglec-9. Fifty-one minutes post-injection, we conducted a low-dose CT for attenuation correction and a whole-body PET scan (one minute/ bed). We also used standard imaging methods, such as vascular ultrasound for the temporal, facial, axillary, carotid, and vertebral arteries, along with aortal MRI and routine laboratory tests.

Results:

A 90-year-old male patient with GCA, diagnosed in 2018, was enrolled. The patient reported recurrent GCA symptoms, including bitemporal headaches and night sweat. At the time of scan, he received methotrexate 15 mg per week and a daily dose of 2 mg prednisolone. His C-reactive protein level was elevated at 21 mg/l. [68Ga]Ga-DOTA-Siglec-9 PET scan revealed increased tracer uptake (SUVmax) in the subclavian artery (2.5), aortic arch (2.9), and heart (2.9), in contrast to an uptake of 1.5 in the liver (Figure 1). Notably, the increased uptake in the descending aorta (3.5) abruptly diminished to 2.2 when passing the diaphragm, with no changes in vessel caliber observed in CT (Figure 1). Vascular ultrasound and MRI did not reveal any pathological findings (data not shown). The injection of [68Ga]Ga-DOTA-Siglec-9 was well tolerated. Whole-body PET images of GCA patient (male, 90 years old) after intravenous injection of 120 MBq of [68Ga]Ga-DOTA-Siglec-9. Distribution of [68Ga]Ga-DOTA-Siglec-9 51 min after injection, based on imaging for one minute per bed position, revealed increased uptake in projection on the aortic and subclavian vessels and the heart. The increased uptake in the descending aorta diminishes abruptly while passing the diaphragm, without any caliber jump in the CT images.

Conclusion:

This study presents the first application of [68Ga]Ga-DOTA-Siglec-9 PET-CT in a GCA patient. PET-CT imaging demonstrated increased tracer uptake in the subclavian artery and aortic arch, with a localized and abrupt reduction. Notably, there were no corresponding findings in conventional imaging. We hypothesize that [68Ga]Ga-DOTA-Siglec-9 PET-CT might offer unique potential for precise, localized mapping of affected vascular tissue in GCA, especially during relapse. This could revolutionize the current diagnostic approach, leading to more targeted strategies for monitoring disease activity. Given these encouraging findings, larger scale studies are essential to fully elucidate the potential role of [68Ga]Ga-DOTA-Siglec-9 PET-CT in the diagnostic landscape of GCA.

REFERENCES:

NIL.

Acknowledgements:

NIL.

Disclosure of Interests:

None declared.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
thermotolerance完成签到,获得积分10
刚刚
zhuanghj5完成签到 ,获得积分10
刚刚
HH完成签到,获得积分10
刚刚
天明完成签到,获得积分10
1秒前
1秒前
1秒前
大模型的应助被极地气旋采纳,获得10
1秒前
琯柠完成签到 ,获得积分10
1秒前
dawntiann完成签到,获得积分10
2秒前
z!完成签到 ,获得积分10
2秒前
卑微小叶发布了新的文献求助20
2秒前
2秒前
呃呃呃呃GG完成签到,获得积分10
2秒前
11完成签到,获得积分10
2秒前
3秒前
3秒前
wjr完成签到,获得积分10
3秒前
单薄熊猫完成签到,获得积分10
3秒前
zjw发布了新的文献求助10
4秒前
4秒前
nanren完成签到 ,获得积分10
4秒前
陈泓宇完成签到,获得积分10
4秒前
4秒前
大钉完成签到,获得积分10
4秒前
LKK完成签到,获得积分10
4秒前
仔仔在完成签到,获得积分10
4秒前
5秒前
caiE完成签到,获得积分10
5秒前
草莓招了完成签到,获得积分10
6秒前
fortuna发布了新的文献求助10
6秒前
小鹿呀发布了新的文献求助30
6秒前
6秒前
6秒前
shoong发布了新的文献求助30
6秒前
科研小南完成签到,获得积分10
6秒前
6秒前
123456发布了新的文献求助10
6秒前
Rocky_Qi发布了新的文献求助10
6秒前
Abolo发布了新的文献求助10
7秒前
LKK发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159542
求助须知:如何正确求助?哪些是违规求助? 9555044
关于积分的说明 21724263
捐赠科研通 7749434
什么是DOI,文献DOI怎么找? 3427246
关于科研通互助平台的介绍 2552263
邀请新用户注册赠送积分活动 2471618